Concepedia

Teresa L. Born

TL

13

Publications

1.4K

Citations

12

H-Index

1991

Active since

Affiliations

Amgen (United States)(Current)

University of California San Diego

IDEX Corporation (United States)

Research & Development Corporation

Teresa L. Born is an author at Amgen (United States) specializing in medicine, cellular physiology, and cell signaling.

Top concepts

Publications per year

1991–2019

13

Publications

13

Cloning of a Novel Receptor Subunit, AcPL, Required for Interleukin-18 Signaling

Teresa L. Born, Elisabeth Thomassen, Timothy A. Bird et al. · Journal of Biological Chemistry · 1998 · 325 citations · Full text

Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering Effects

Kannan Gunasekaran, Martin Pentony, Min Shen et al. · Journal of Biological Chemistry · 2010 · 279 citations · Full text

, , +11

A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response

Teresa L. Born, Lynda A. Morrison, David J. Esteban et al. · The Journal of Immunology · 2000 · 180 citations

Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B.

S Swanson, Teresa L. Born, Lynne D. Zydowsky et al. · Proceedings of the National Academy of Sciences · 1992 · 165 citations · Full text

, , +13

Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways

Kent Miner, Katja Labitzke, Benxian Liu et al. · Frontiers in Pharmacology · 2019 · 132 citations · Full text

Rows per page

1–5 of 13